Two isolates from water, D16Q19 and D16R27, were shown to be highly similar in their 16S rRNA, 16S-23S internal transcribed spacer (ITS), hsp65 and rpoB gene sequences to 'Mycobacterium franklinii' DSM 45524, described in 2011 but with the name not validly published. They are all nonpigmented rapid growers and are related phenotypically and genetically to the Mycobacterium chelonae-Mycobacterium abscessus group. Extensive characterization by phenotypic analysis, biochemical tests, drug susceptibility testing, PCR restriction enzyme analysis of the hsp65 gene and ITS, DNA sequencing of housekeeping genes and DNA-DNA hybridization demonstrated that 'M. franklinii' DSM 45524, D16Q19 and D16R27 belong to a single species that is separated from other members of the M. chelonae-M. abscessus group. On the basis of these results we propose the formal recognition of Mycobacterium franklinii sp. nov. Strain DSM 45524 T (5ATCC BAA-2149 T ) is the type strain.
The Mycobacterium chelonae-Mycobacterium abscessus group comprises closely related rapidly growing mycobacteria. They are widespread saprophytes that can cause several opportunistic infections in humans, ranging from localized abscesses to pulmonary and disseminated disease (Brown-Elliott & Wallace, 2002; Wallace et al., 1983) . Skin and soft-tissue infections caused by members of the M. chelonae-M. abscessus group have been reported increasingly in recent years, representing a serious public health problem in some settings. The ubiquitous distribution of these organisms facilitates the contamination of medical equipment and solutions, which may be associated with the growing number of therapeutic interventions leading to nosocomial infections and outbreaks (Brown-Elliott & Wallace, 2012; Tortoli, 2009 ).
Until 2007, the M. chelonae-M. abscessus group was composed of Mycobacterium chelonae, Mycobacterium abscessus (Kusunoki & Ezaki, 1992) , Mycobacterium immunogenum (Wilson et al., 2001) , Mycobacterium massiliense (Adékambi et al., 2004 (Adékambi et al., , 2006b (Whipps et al., 2007) . Recently, this group has undergone taxonomic changes, including the unification of M. abscessus, M. massiliense and M. bolletii in a single species (M. abscessus) with two subspecies (M. abscessus subsp. abscessus and M. abscessus subsp. bolletii). Strains formerly representing M. massiliense were reclassified as M. abscessus subsp. bolletii (Leão et al., 2009 (Leão et al., , 2011 . Although beyond the scope of this paper, whole genomic sequencing has recently provided evidence that there are indeed three taxonomic groups within M. abscessus. It is not clear yet how this will affect the 2011 reclassification (Tettelin et al., 2014) .
In 2011, Simmon & Brown-Elliott et al. studied a group of clinical isolates from Pennsylvania, and primarily the north-eastern USA, that were initially misidentified as M. chelonae with an atypical antimicrobial drug susceptibility profile (Simmon et al., 2011) . This study included the proposal of 'Mycobacterium franklinii' as a new member of the M. chelonae-M. abscessus group, but this name has not been validly published.
During taxonomic studies of isolates from the collection of Professor Françoise Portaels (Antwerp, Belgium), two isolates (D16Q19 and D16R27) showed high similarity with 'M. franklinii' by sequencing of 16S rRNA, hsp65 and rpoB genes and the 16S-23S internal transcribed spacer (ITS). Strains D16Q19 and D16R27 were isolated in Germany by Professor Roland Schulze-Röbbecke (Düsselforf, Germany) from water works and tap water, respectively.
The aim of the present study was to examine the taxonomic position of these two isolates and 'M. Cultures were grown on solid-phase media including Middlebrook 7H10 (Becton Dickinson Co, Sparks, MD, USA) and Luria-Bertani agar and in liquid medium including Mueller-Hinton (Becton Dickinson) and Luria-Bertani broth with 0.1 % Tween 80. All cultures were incubated at 28-30 8C. Microscopic examination of isolated colonies by Ziehl-Neelsen staining showed that isolates D16Q19, D16R27 and DSM 45524 T were acidfast bacilli. Pigment production, single-source carbon utilization (mannitol, inositol and citrate), growth at 26 8C and 37 8C and the ability to grow in the presence of 5 % NaCl, 0.2 % picric acid, para-nitrobenzoic acid (PNB) and nitrite were performed on 7H10 medium. Nitrate reduction and Tween 80 hydrolysis were also examined. The results of these tests were read after 7 and 14 days of incubation at 28 8C, except for Tween 80 hydrolysis, which was read after 5 and 10 days, as described in standard protocols for biochemical testing of mycobacteria (Kent & Kubica, 1985; Leão et al., 2004; Tsukamura, 1984) .
Isolates D16Q19, D16R27 and DSM 45524 T exhibited indistinguishable phenotypic and biochemical characteristics, which are indicated in Table S1 (available in the online Supplementary Material). Colonies that appeared on Middlebrook 7H10 and Luria-Bertani agar after aerobic incubation were nonpigmented. On these solid media, visible growth required 3 to 5 days at 25 8C to 37 8C; optimum growth occurred at 28 8C. The bacterial cells showed tendency to form large clumps when grown in liquid media and the use of 0.1 % Tween 80 helped to obtain dispersed growth. They grew in the presence of 5 % NaCl, picric acid, PNB and nitrite. They were negative for nitrate reduction and Tween hydrolysis and growth did not occur when mannitol or inositol was used as a singlesource of carbon. D16Q19, D16R27, M. chelonae ATCC 35752 T and M. immunogenum ATCC 700505 T grew in the presence of citrate but not strain DSM 45524 T or the other type strains of the M. chelonae-M. abscessus group. These phenotypic and biochemical tests were not useful for distinguishing D16Q19, D16R27 and DSM 45524 T from other members of the M. chelonae-M. abscessus group.
Antimicrobial susceptibility testing was performed in cation-supplemented Mueller-Hinton broth by the microdilution method, according to the recommendations of the Clinical and Laboratory Standards Institute for rapidly growing mycobacteria (CLSI, 2011). The antimicrobials tested were amikacin, cefoxitin, ciprofloxacin, clarithromycin, doxycycline, minocycline, moxifloxacin and tobramycin. According to CLSI interpretative standards, isolates D16Q19, D16R27 and DSM 45524 T were susceptible to amikacin, ciprofloxacin, doxycycline, minocycline and moxifloxacin. D16Q19 and D16R27 were susceptible to clarithromycin at 3 days of incubation but extended clarithromycin MICs (14 days (Simmon et al., 2011) . D16Q19, D16R27 and DSM 45524 T were more susceptible to antimicrobial drugs than the other members of the M. chelonae-M. abscessus group, but studies of larger strain numbers have shown greater MIC variability than exhibited by these reference type strains (Table 1) .
GenoType Mycobacterium common mycobacteria (CM) and additional species (AS) assays (Hain Lifescience), two commercial DNA strip assays for mycobacteria identification, were performed according to manufacturer's instructions. Using GenoType CM, isolates D16Q19, D16R27 and DSM 45524 T showed the M. chelonae profile (hybridization with probes 5 and 10). They showed the same GenoType AS profile, hybridization with probe 12, which assigns the isolates to a species of mycobacteria different from the 18 species identifiable with the AS strip.
For molecular identification by PCR restriction enzyme analysis (PRA) of the hsp65 gene and ITS, DNA was prepared by boiling one loop-full of bacteria for 10 min in 300 ml TET (10 mM Tris, 1 mM EDTA, 1 % Triton X-100, pH 8.0) followed by centrifugation at 14 000 g for 2 min. For PRA-hsp65, a 441 bp fragment of the hsp65 gene was amplified using primers Tb11 and Tb12 (Table S2) , as described by Telenti et al. (1993) . The amplicons were digested in two separate tubes with Bst EII and Hae III restriction enzymes. For PRA-ITS, the ITS fragment was amplified using primers Sp1 and Sp2 (Table S2) , as described by Roth et al. (2000) . ITS amplicons were digested with Taq I restriction enzyme. The digestion products of both PRA-hsp65 and PRA-ITS were visualized after electrophoresis in 3 % agarose gels stained with ethidium bromide, using 50 bp ladder as the molecular size standard. The restriction fragment sizes were estimated using the BioNumerics program version 5.1 (Applied Maths) and compared with the patterns included in the PRASITE (http://app.chuv.ch/prasite/index.html) for PRA-hsp65 and published by Roth et al. (2000) for PRA-ITS.
Isolates D16Q19, D16R27 and DSM 45524 T showed indistinguishable PRA-hsp65 patterns -Bst EII (320 and 130 bp) and Hae III (200, 70, 60 and 55 bp). They showed the same PRA-ITS pattern -Taq I (225 and 30 bp), which is common to M. abscessus. Both assays, GenoType and PRA, were not useful for distinguishing D16Q19, D16R27 and DSM 45524 T from other members of the M. chelonae-M. abscessus group (data not shown).
Partial sequences of the 16S rRNA gene (Adékambi & Drancourt, 2004; Gomila et al., 2007; Harmsen et al., 2003) , hsp65 (Telenti et al., 1993 ), rpoB (Adékambi et al., 2003 and ITS (Roth et al., 2000) were obtained with isolates D16Q19 and D16R27. The primers used for PCR amplification and sequencing are listed in Table S2 . PCR products were purified using a QIAquick PCR purification kit (Qiagen). Dideoxy sequencing was performed using a BigDye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems) and run in an ABI PRISM 3100 DNA Analyser (Applied Biosystems). Sequences from both isolates D16Q19 and D16R27 shared 100 % identity and only the sequences from isolate D16R27 were deposited in the Gen-Bank database. The corresponding sequences of the M. chelonae-M. abscessus group type strains were retrieved from the GenBank database (http://www.ncbi.nlm.nih.gov/ genbank/). The hsp65 and rpoB genes of DSM 45524 T and Table 1 . Antimicrobial susceptibility results with isolates and type strains included here and 25 CV isolates from the previous study (Simmon et al., 2011) Isolates/strains: 1, D16Q19; 2, D16R27; 3, Mycobacterium franklinii sp. nov. DSM 45524 T ; that were analyzed by Simmon & Brown-Elliott in a previous study (Simmon et al. 2011 ) 4, range of results of 25 CV* isolates; 5, M. abscessus subsp. abscessus ATCC 19977 T ; 6, M. abscessus subsp. bolletii CCUG 50184 T ; 7, M. chelonae ATCC 35752 T ; 8, M. immunogenum ATCC 700505 T ; 9, M. salmoniphilum ATCC 13758 T . The antimicrobial susceptibility breakpoints were those established by CLSI (2011) for rapidly growing mycobacteria. ND, Not determined; n, number of isolates tested by Simmon & Brown-Elliott et al. (Simmon et al., 2011) . (Simmon et al., 2011). the rpoB gene of M. salmoniphilum ATCC 13758 T were resequenced, as the sequences deposited in the GenBank database were incomplete. All sequences of isolates D16R27 and D16Q19 showed the highest sequence similarity with the corresponding sequences of DSM 45524 T , suggesting that they belong to the same taxon (Table S3 ). Sequence alignments and phylogenetic trees were reconstructed by using the neighbour-joining method with the Kimura two-parameter distance correction model and 1000 bootstrap replications in MEGA6 (Tamura et al., 2013) (Fig. 1) .
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Isolate D16R27 was selected to perform DNA-DNA hybridization (DDH) experiments. High molecular mass DNA was prepared from 2 g cell mass using the protocol described by Pitcher et al. (1989) with modifications. After centrifugation, cells were inactivated at 90 8C for 30 min and resuspended in 3 ml of lysis buffer containing 200 mg RNase ml 21 , 25 mg fresh lysozyme ml 21 and 100 U mutanolysine ml 21 . The suspensions were incubated overnight at 37 8C. Chloroform/isoamyl alcohol extraction, RNase treatment and ethanol precipitation were performed as described by Marmur (1961) . DDH was performed with photobiotin-labelled probes in microplate wells, as described by Ezaki et al. (1989) , using an HTS7000 Bio Assay Reader (Perkin-Elmer) for fluorescence measurements. The hybridization temperature was 50 8C, calculated on the basis of the DNA G+C contents of the isolates and type strains, estimated as described by Mesbah & Whitman (1989) . The DNA G+C content of isolates D16R27 and D16Q19 was 64.2 mol%. The DNA G+C content of M. abscessus subsp. abscessus ATCC 19977 T , M. chelonae ATCC 35752 T , M. immunogenum ATCC 700505 T , M. salmoniphilum ATCC 13758 T and DSM 45524 T was 64.0, 64.1, 64.2, 64.3 and 64.1 mol%, respectively. These values are consistent with the DNA G+C contents of this genus, between 59 and 66 mol% (Devulder et al., 2005) . DDH values are presented as means of reciprocal experiments, performed in quadruplicate hybridization reactions ( M. abscessus subsp. bolletii CCUG 48898* 83 0.005 Fig. 1 . Neighbour-joining tree of concatenated 16S rRNA gene, ITS, hsp65 gene and rpoB gene sequences from the M. chelonae-M. abscessus group type strains and isolates D16Q19 and D16R27. The culture collection strain designation for the 16S rRNA gene sequence is shown next to the species name. GenBank accession numbers of the 16S rRNA, ITS, hsp65 and rpoB gene sequences and alternative culture collections repositories for the other DNA targets are noted in Table  S3 . Branch support is recorded at nodes as a percentage of 1000 bootstrap iterations. Bar, 0.005 substitutions per nucleotide position. *CCUG 48898 T is the type strain of M. massiliense. Cells are acid-fast bacilli and visible growth on solid media requires 3-5 days of incubation at 28 uC. Colonies are nonpigmented and growth occurs in the presence of 5% NaCl, picric acid, PNB and nitrite. Growth is not observed when mannitol or inositol is used as single-source of carbon. The type strain does not grow when citrate is used as singlesource of carbon. Negative reactions are observed for nitrate reduction and Tween 80 hydrolysis. Conventional biochemical tests cannot distinguish M. franklinii from other members of the M. chelonae-M. abscessus group and should not be used as confirmatory tests for identification of this species. Susceptible to clarithromycin at 3 days. Eight of the original 25 isolates have clarithromycin MICs at j2 at 14 days. Susceptible to amikacin, ciprofloxacin, moxifloxacin, doxycycline and minocycline. Variable susceptibility to tobramycin and cefoxitin (see Table 1 ). Partial sequencing of rpoB gene can distinguish M. franklinii from other members of the M. chelonae-M. abscessus group -the M. franklinii sequence has a 726 bp fragment length while the corresponding sequences of the type strains of the M. chelonae-M. abscessus group have a 711 bp fragment length. The PRA-hsp65 pattern that characterizes M. franklinii is Bst EII (320 and 130 bp) and Hae III (200, 70, 60 and 55 bp); these fragment sizes are closely related to the pattern of M. immunogenum type 2.
The type strain is DSM 45524 T (5ATCC BAA-2149 T ).
